Portfolio concentration
As of April 30, 2026 · N-PORT
Holdings
63
Top-10 weight
36.93%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
38
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
786.0
Holdings
As of April 30, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | LILLY ELI and CO | — | 775 | $724.32K | 8.89% |
| 2 | ASTRAZENECA PLC | — | 2,029 | $384.95K | 4.73% |
| 3 | GILEAD SCIENCES INC | — | 2,647 | $346.33K | 4.25% |
| 4 | JOHNSON&JOHNSON | — | 1,129 | $259.50K | 3.19% |
| 5 | NEKTAR THERAPEUTICS | — | 3,038 | $258.35K | 3.17% |
| 6 | NATERA INC | — | 1,151 | $237.29K | 2.91% |
| 7 | TARSUS PHARMACEUTICALS INC | — | 3,622 | $230.40K | 2.83% |
| 8 | GUARDANT HEALTH INC | — | 2,459 | $214.13K | 2.63% |
| 9 | ARGENX SE | — | 259 | $203.11K | 2.49% |
| 10 | Novartis AG (Registered) | NVSEF | 1,356 | $200.40K | 2.46% |
| 11 | CVS HEALTH CORP | — | 2,320 | $193.23K | 2.37% |
| 12 | MADRIGAL PHARMACEUTICALS INC | — | 350 | $181.09K | 2.22% |
| 13 | INTUITIVE SURGICAL INC | — | 393 | $179.84K | 2.21% |
| 14 | COGENT BIOSCIENCES INC | — | 4,983 | $178.34K | 2.19% |
| 15 | GALDERMA GROUP A | — | 818 | $171.61K | 2.11% |
| 16 | UNITEDHEALTH GRP | — | 461 | $170.79K | 2.10% |
| 17 | CELCUITY INC | — | 1,349 | $163.70K | 2.01% |
| 18 | BRIDGEBIO PHARMA INC | — | 2,278 | $161.99K | 1.99% |
| 19 | CENCORA INC | — | 525 | $161.71K | 1.99% |
| 20 | Ascendis Pharma A/S | — | 698 | $160.11K | 1.97% |
| 21 | Abivax SA SPONSORED ADS | ABVX US | 1,296 | $152.12K | 1.87% |
| 22 | EDWARDS LIFESCIENCES CORP | — | 1,775 | $148.21K | 1.82% |
| 23 | FIXED INC CLEARING CORP.REPO | — | 144,818 | $144.82K | 1.78% |
| 24 | MIRUM PHARMACEUTICALS INC | — | 1,467 | $142.75K | 1.75% |
| 25 | UCB SA | — | 522 | $142.14K | 1.74% |
| 26 | MONEY MARKET FUND | FRGXX | 139,928 | $139.93K | 1.72% |
| 27 | DIANTHUS THERAPEUTICS INC | — | 1,575 | $138.28K | 1.70% |
| 28 | UNITED THERAPEUTICS CORP DEL | — | 234 | $133.70K | 1.64% |
| 29 | VERTEX PHARMACEUTICALS INC | — | 311 | $132.92K | 1.63% |
| 30 | THERMO FISHER SCIENTIFIC INC | — | 252 | $120.70K | 1.48% |
| 31 | REVOLUTION MEDICINES INC | — | 764 | $110.11K | 1.35% |
| 32 | TEVA PHARMACEUTICAL IND ADR | — | 2,957 | $103.70K | 1.27% |
| 33 | ADAPTIVE BIOTECHNOLOGIES CORP | — | 6,769 | $95.44K | 1.17% |
| 34 | PTC THERAPEUTICS INC | — | 1,401 | $91.15K | 1.12% |
| 35 | INSMED INC | — | 630 | $85.89K | 1.05% |
| 36 | MINERALYS THERAPEUTICS INC | — | 3,220 | $85.81K | 1.05% |
| 37 | OTSUKA HOLDINGS | — | 1,162 | $84.69K | 1.04% |
| 38 | CG ONCOLOGY INC | — | 1,223 | $81.62K | 1.00% |
| 39 | BEONE MEDICINE-H | — | 3,387 | $76.88K | 0.94% |
| 40 | RHYTHM PHARMACEUTICALS INC | — | 942 | $76.64K | 0.94% |
| 41 | GLAUKOS CORP | — | 526 | $75.57K | 0.93% |
| 42 | ARROWHEAD PHARMACEUTICALS INC | — | 962 | $70.69K | 0.87% |
| 43 | 10X GENOMICS INC | — | 3,200 | $70.56K | 0.87% |
| 44 | HEARTFLOW INC | — | 2,360 | $70.23K | 0.86% |
| 45 | ENCOMPASS HEALTH CORP | — | 677 | $67.70K | 0.83% |
| 46 | GENEDX HOLDINGS CORP-A | — | 1,046 | $65.78K | 0.81% |
| 47 | TRANSMEDICS GROUP INC | — | 650 | $65.51K | 0.80% |
| 48 | DBV TECHNOLOGIES SA SPON ADR | DBVT | 2,973 | $62.43K | 0.77% |
| 49 | STRYKER CORP | — | 186 | $58.61K | 0.72% |
| 50 | PROTAGONIST THERAPEUTICS INC | — | 580 | $57.40K | 0.70% |
1 / 2
Next ›
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.